Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Incontinence 1Prostatic Neoplasms 1Neoplasms 1Erectile Dysfunction 1

Interventions

enzalutamide 4pembrolizumab 3Docetaxel 3apalutamide 2Testosterone 2Prednisone 2Cholecalciferol 2Celecoxib 2Androgen Antagonists 2Abiraterone Acetate 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2relugolix 1olaparib 1nilutamide 1histrelin 1gallium 68 PSMA-11 1capivasertib 1bicalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abiraterone 1Yoga 1Triptorelin Pamoate 1Tablets 1Simvastatin 1Sildenafil Citrate 1Pluvicto 1Perioperative Care 1Pentoxifylline 1Methylprednisolone 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Prostatic Neoplasms × Yoga × Clear all
NCT05929300 2024-09-19

A Yoga Program for Patients Undergoing Prostate Cancer Surgery

VA Office of Research and Development

Phase NA Withdrawn
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡